I agree that this site is using cookies. You can find further informations here.
X
Baker, Sharyn D.
140  results:
OpenAccess-fulltext X
Search for persons X
?
1

Framework of clonal mutations concurrent with WT1 mutations..:

Bhatnagar, Bhavana ; Kohlschmidt, Jessica ; Orwick, Shelley J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10448419/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

P512: A PHASE 1B/2 STUDY OF TP-0903 AND DECITABINE TARGETIN..:

Mims, Alice ; Huang, Ying ; Eisenmann, Eric...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428724/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

P422: TARGETING THE WT1MUT-MIR-193A TRANSCRIPTIONAL AXIS WI..:

Yang, Xining ; Krowiorz, Kathrin ; Buelow, Daelynn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428817/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
4

DNA methyltransferase inhibitor exposure–response: Challeng..:

Kagan, Amanda B ; Garrison, Dominique A ; Anders, Nicole M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432879/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
5

Framework of clonal mutations concurrent with WT1 mutations..:

Orwick, Shelley ; Bhatnagar, Bhavana ; Baker, Sharyn.
https://zenodo.org/communities/dryad.  , 2023
Link: https://zenodo.org/recor..
 
?
6

Targeting a xenobiotic transporter to ameliorate vincristin..:

Li, Yang ; Drabison, Thomas ; Nepal, Mahesh...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443802/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
7

Author Correction: Increased renal elimination of endogenou..:

Persaud, Avinash K ; Bernier, Matthew C ; Massey, Michael A...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247706/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
8

Itraconazole-Induced Increases in Gilteritinib Exposure Are..:

Garrison, Dominique A ; Jin, Yan ; Talebi, Zahra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610999/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
9

Determination of the endogenous OATP1B biomarkers glycochen..:

Jin, Yan ; Li, Yang ; Eisenmann, Eric D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588625/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
10

Selinexor combined with ibrutinib demonstrates tolerability..:

Stephens, Deborah M ; Huang, Ying ; Ruppert, Amy S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364840/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
11

Preclinical and pilot study of type I FLT3 tyrosine kinase ..:

Inaba, Hiroto ; van Oosterwijk, Jolieke G ; Panetta, John C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9197875/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
?
12

Targeting OCT3 attenuates doxorubicin-induced cardiac injur:

Huang, Kevin M ; Zavorka Thomas, Megan ; Magdy, Tarek...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865186/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
13

Kidney toxicity of the BRAF-kinase inhibitor vemurafenib is..:

Bai, Yuntao ; Kim, Ji Young ; Bisunke, Bijay...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608726/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
14

Development, validation, and application of an LC-MS/MS met..:

Garrison, Dominique A ; Jin, Yan ; Uddin, Muhammad Erfan..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687142/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
15

Gilteritinib-induced upregulation of S100A9 is mediated thr..:

Zavorka Thomas, Megan E ; Jeon, Jae Yoon ; Talebi, Zahra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9153019/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
1-15